Abstract
Calcification, a phenomenon often regarded by pathologists little more than evidence of cell death, is becoming recognized to be important in the dynamics of a variety of diseases from which millions of beings suffer in all ages. In calcification, all that is needed for crystal formation to start is nidi (nuclei) and an environment of available dissolved components at or near saturation concentrations, along with the absence of inhibitors for crystal formation. Calcifying nanoparticles (CNP) are the first calcium phosphate mineral containing particles isolated from human blood and were detected in numerous pathologic calcification related diseases. Controversy and critical role of CNP as nidi and triggering factor in human pathologic calcification are discussed.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- BA:
-
biological apatite
- CNP:
-
calcifying nanoparticles
- HA:
-
hydroxyapatite
- KS:
-
kidney stone
- MV:
-
matrix vesicles
- NLP:
-
nanobacteria-like particles
- PKD:
-
polycystic kidney disease
- RP:
-
Randall's plaques
- SWL:
-
extracorporeal shock wave lithotripsy
- TEM:
-
transmission electron microscopy
- TM:
-
testicular microlithiasis
References
Tadic D, Peters F, Epple M 2002 Continuous synthesis of amorphous carbonated apatites. Biomaterials 23: 2553–2559
Zaidi AN, Ceneviva GD, Phipps LM, Dettorre MD, Mart CR, Thomas NJ 2005 Myocardial calcification caused by secondary hyperparathyroidism due to dietary deficiency of calcium and vitamin D. Pediatr Cardiol 26: 460–463
Ray M, Dixit A, Singhi P 2002 Nephrogenic diabetes insipidus with intracranial calcification. Indian Pediatr 39: 197–202
Carson DA 1998 An infectious origin of extraskeletal calcification. Proc Natl Acad Sci USA 95: 7846–7847
Pachman LM, Boskey AL 2006 Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis. Curr Rheumatol Rep 8: 236–243
Rezaei-Kanavi M, Javadi MA, Mirbabaei-Ghafghazi F 2009 Intraocular lens calcification; a clinicopathologic report. J Ophthalmic Vis Res 4: 122–124
Peters W, Smith D, Lugowski S, Pritzker K, Holmyard D 2001 Calcification properties of saline-filled breast implants. Plast Reconstr Surg 107: 356–363
Pearle MS, Calhourn EA, Curhan GC 2005 Urologic diseases in America project: urolithiasis. J Urol 173: 848–857
Stamatelou KK, Francis ME, Jones CA, Curhan GC 2003 Time trends in reported prevalence of kidney stones in the United Sates: 1976–1994. Kidney Int 63: 1817–1823
Soucie JM, Coates R, McClellan W, Austin H, Thun M 1996 Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143: 487–495
Brikowski TH, Lotan Y, Pearle MS 2008 Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105: 9841–9846
Evan AP 2009 Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. Available at: http://www.springerlink.com/content/41507435785w4261/fulltext.pdf. Accessed January 12, 2010
Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC 2009 Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4: 804–811
Momohara C, Tsujihata M, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A 2009 Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis. J Urol 182: 1201–1209
Parks JH, Coe FL, Evan AP, Worcester EM 2009 Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24: 130–136
Klee LW, Brito CG, Lingeman JE 1991 The clinical implications of brushite calculi. J Urol 145: 715–718
El-Abbadi M, Giachelli CM 2005 Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. Curr Opin Nephrol Hypertens 14: 519–524
Levy RJ, Schoen FJ, Anderson HC, Harasaki H, Koch TH, Brown W, Lian JB, Cumming R, Gavin JB 1991 Cardiovascular implant calcification: a survey and update. Biomaterials 12: 707–714
Demer LL 1995 A skeleton in the atherosclerosis closet. Circulation 92: 2029–2032
Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K 1996 Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation 94: 1175–1192
Jono S, Shioi A, Ikari Y, Nishizawa Y 2006 Vascular calcification in chronic kidney disease. J Bone Miner Metab 24: 176–181
Blair B, Fabrizio M 2000 Pharmacology for renal calculi. Expert Opin Pharmacother 1: 435–441
Sohshang HL, Singh MA, Singh NG, Singh SR 2000 Biochemical and bacteriological study of urinary calculi. J Commun Dis 32: 216–221
Driessens FC, Verbeeck RM, van Dijk JW 1989 Plasma calcium difference between man and vertebrates. Comp Biochem Physiol A Comp Physiol 93: 651–654
Chen NX, O'Neill KD, Chen X, Moe SM 2008 Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 23: 1798–1805
Poole AR, Matsui Y, Hinek A, Lee ER 1989 Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec 224: 167–179
Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR 2003 Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A 66: 93–102
Dewanjee MK, Solis E, Lanker J, Mackey ST, Lombardo GM, Tidwell C, Ellefsen RD, Kaye MP 1986 Effect of diphosphonate binding to collagen upon inhibition of calcification and promotion of spontaneous endothelial cell coverage on tissue valve prostheses. ASAIO Trans 32: 24–29
Lewinski N, Colvin V, Drezek R 2008 Cytotoxicity of Nanoparticles. Small 4: 26–49
Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W 2007 Size-Dependent Cytotoxicity of Gold Nanoparticles. Small 3: 1941–1949
Inayat-Hussain SH, Rajab NF, Roslie H, Hussin AA, Ali AM, Annuar BO 2004 Cell death induced by hydroxyapatite on L929 fibroblast cells. Med J Malaysia 59: 176–177
Barroug A, Kuhn LT, Gerstenfeld LC, Glimcher MJ 2004 Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J Orthop Res 22: 703–708
Telli C, Serper A, Dogan A, Guc D 1999 Evaluation of the cytotoxicity of calcium phosphate root canal sealers by MTT assay. J Endod 25: 811–813
Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, Alt V 2005 Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26: 2677–2684
Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T, Yoshikawa H 2002 Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 59: 110–117
Albiar E, Holds JB 1992 Hydroxyapatite orbital implants: indications for use and nursing considerations. J Ophthalmic Nurs Technol 11: 71–76
Mizushima Y, Ikoma T, Tanaka J, Hoshi K, Ishihara T, Ogawa Y, Ueno A 2006 Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Release 110: 260–265
Bouladjine A, Al-Kattan A, Dufour P, Drouet C 2009 New advances in nanocrystalline apatite colloids intended for cellular drug delivery. Langmuir 25: 12256–12265
Tazaki J, Murata M, Akazawa T, Yamamoto M, Ito K, Arisue M, Shibata T, Tabata Y 2009 BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. Biomed Mater Eng 19: 141–146
Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H, Takakura Y, Ohgushi H 2009 In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs 33: 474–481
Chang WC, Tsou HK, Chen WS, Chen CC, Shen CC 2009 Preliminary comparison of radiolucent cages containing either autogenous cancellous bone or hydroxyapatite graft in multilevel cervical fusion. J Clin Neurosci 16: 793–796
McCarty DJ 2008 Basic Ca phosphate and calcium oxalate crystal deposition diseases. In: Porter RS, Kaplan JL (eds) The Merck Manual Online. Merck & Co., Inc., Whitehouse Station. Available at: http://www.merck.com/mmpe/sec04/ch035/ch035d.html. Accessed at December 5, 2009
Kajander EO, Çiftçioglu N 1998 Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95: 8274–8279
Puskás LG, Tiszlavicz L, Rázga Z, Torday LL, Krenács T, Papp JG 2005 Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56: 233–245
Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR III, Folk RL, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske JC 2004 Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287: H1115–H1124
Çiftçioğlu N, McKay DS, Kajander EO 2003 Association between nanobacteria and periodontal disease. Circulation 108: e58–e59
Çiftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO 1999 Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56: 1893–1898
Kajander EO, Tahvanien E, Kuronen I, Çiftçioğlu N 1994 Comparison of Staphylococci and novel bacteria-like particles from blood. Zentralbl Bakteriol Suppl 26: 147–149
Çiftçioğlu N, Pelttari A, Kajander EO 1997 Extrardinary growth phases of Nanobacteria isolated from mammalian blood. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, San Diego, CA, 3111: 429–435
Çiftçioğlu N, Aho KM, McKay DS, Kajander EO 2007 Are apatite nanoparticles safe?. Lancet 369: 2078
Mathew G, McKay DS, Ciftçioglu N 2008 Do blood-borne calcifying nanoparticles self-propagate?. Int J Nanomedicine 3: 265–275
Kajander EO, Björklund M, Çiftçioğlu N 1999 Suggestions from observations on nanobacteria isolated from blood. Size Limits of Very Small Microorganisms: Proceedings of a Workshop, Steering Group on Astrobiology of the Space Studies Board, National Research Council, Washington DC, pp 50–55.
Björklund M, Çiftçioğlu N, Kajander EO 1998 Extraordinary survival of nanobacteria under extreme conditions. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, San Jose, CA 3441: 123–129.
Çiftçioğlu N, McKay DS, Mathew G, Kajander EO 2006 Nanobacteria: Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Investig Med 54: 385–394
Çiftçioğlu N, Miller-Hjelle MA, Hjelle JT, Kajander EO 2002 Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46: 2077–2086
Çiftçioğlu N 2002 Kidney stone formation: an infectious disease?. Japanese Journal of Urological Surgery 15: 228–232
Kajander EO, Çiftçioğlu N, Aho K, Garcia-Cuerpo E 2003 Characteristics of Nanobacteria and their possible role in stone formation. Urol Res 31: 47–54
Shiekh FA, Khullar M, Singh SK 2006 Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 34: 53–57
Ciftçioğlu N, Vejdani K, Lee O, Mathew G, Aho KM, Kajander EO, McKay DS, Jones JA, Stoller ML 2008 Association between Randall's plaque and calcifying nanoparticles. Int J Nanomedicine 3: 105–115
Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, Liu W, Miao XY, Wang QW, Huang SF, Yang J, Kajander EO, Çiftçioğlu N 2005 Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 118: 421–424
Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, Liu W, Tan AL, Miao XY, Wang QW, Huang SF, Kajander EO, Çiftçioğlu N 2003 Nanobacteria in serum, bile and gallbladder mucosa of cholecystolithiasis patients. Zhonghua Wai Ke Za Zhi 41: 267–270
Çiftçioğlu N, Çiftçioğlu V, Vali H, Turcott E, Kajander EO 1998 Sedimentary rocks in our mouth: Dental pulp stones made by Nanobacteria. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, 3441: 130–135
Zhang SM, Tian F, Jiang XQ, Li J, Xu C, Guo XK, Zhang FQ 2009 Evidence for calcifying nanoparticles in gingival crevicular fluid and dental calculus in periodontitis. J Periodontol 80: 1462–1470
Zeng JF, Zhang W, Jiang HW, Ling JQ 2006 [Isolation, cultivation and initial identification of Nanobacteria from dental pulp stone.]. Zhonghua Kou Qiang Yi Xue Za Zhi 41: 498–501
Zhou Z, Hong L, Shen X, Rao X, Jin X, Lu G, Li L, Xiong E, Li W, Zhang J, Chen Z, Pan J, Song B 2008 Detection of nanobacteria infection in type III prostatitis. Urology 71: 1091–1095. Erratum in: Urology 72:723
Wood HM, Shoskes DA 2006 The role of nanobacteria in urologic disease. World J Urol 24: 51–54
Shoskes DA, Thomas KD, Gomez E 2005 Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 173: 474–477
Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Çiftçioğlu N 2000 Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57: 2360–2374
Kajander EO, Çiftçioğlu N, Miller-Hjelle MA, Hjelle JT 2001 Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr Opin Nephrol Hypertens 10: 445–452
Hudelist G, Singer CF, Kubista E, Manavi M, Mueller R, Pischinger K, Czerwenka K 2004 Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 45: 633–637
Wainwright M 1999 Nanobacteria and associated ‘elementary bodies' in human disease and cancer. Microbiology 145: 2623–2624
Çiftçioglu N, Kajander EO 1998 Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4: 259–270
Åkerman KK, Kuikka JT, Çiftçioglu N, Parkkinen J, Bergström KA, Kuronen I, Kajander EO 1997 Radiolabeling and in vivo distribution of nanobacteria in rabbit. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. The International Society for Optical Engineering, Proceedings of SPIE, San Diego, CA, 3111: 436–442.
Randall A 1937 The origin and growth of renal calculi. Ann Surg 105: 1009–1027
Matlaga BR, Coe FL, Evan AP, Lingeman JE 2007 The role of Randall's palques in the pathogenesis of calcium stones. J Urol 177: 31–38
Burton EM, Hanna JD, Mercado-Deane MG 1995 Nephrocalcinosis in a child with autosomal dominant polycystic kidney disease and a prolapsing ectopic ureterocele. Pediatr Radiol 25: 462–465
Muezzinoglu B, Gurbuz Y 2001 Stromal microcalcification in prostate. Malays J Pathol 23: 31–33
Anim JT, Kehinde EO, Prasad A, Prasad A, Mojiminiyi OA, Ali Y, Al-Awadi KA 2006 Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men. Int Urol Nephrol 38: 27–32
Torres Ramirez C, Aguilar Ruiz J, Zuluaga Gomez A 1981 Ultrastructure of primary or endogenous prostatic calculi. Scanning electron microscopic study. Arch Esp Urol 34: 13–22
Zhang QH, Lu GS, Shen XC, Zhou ZS, Fang Q, Zhang X, Li LK, Jin XY, Song B 2009 Nanobacteria may be linked to testicular microlithiasis in infertility. J Androl, in press
Maniscalco BS, Taylor KA 2004 Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11: 95–101
Hu YR, Zhao Y, Sun YW, Lü WD, Liu ZL, Li JM, Wu ZS, Tang H, Gao F, Zhou XM 2009 Detection of nanobacteria-like material from calcified cardiac valves with rheumatic heart disease. Cardiovasc Pathol, in press
Bellah RD, Zawodniak L, Librizzi RJ, Harris MC 1992 Idiopathic arterial calcification of infancy: Prenatal and postnatal effects of therapy in an infant. J Pediatr 121: 930–933
Sedivy R, Battistutti WB 2003 Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 111: 951–954
Jelic TM, Malas AM, Groves SS, Jin B, Mellen PF, Osborne G, Roque R, Rosencrance JG, Chang HH 2004 Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 97: 194–198
Sommer AP, Pavlath AE 2005 Primordial proteins and HIV. J Proteome Res 4: 633–636
Pretorius AM, Sommer AP, Aho KM, Kajander EO 2004 HIV and nanobacteria. HIV Med 5: 391–393
Sommer AP 2004 Could reduced bone mineral densities in HIV be caused by nanobacteria?. J Proteome Res 3: 670–672
Miller-Hjelle MA, Hjelle JT, Çiftçioğlu N, Kajander EO 2003 Nanobacteria: methods for growth and identification of this recently discovered calciferous agent. In: Olson WP (ed) Rapid Analytical Microbiology, the Chemistry and Physics of Microbial Identification. Davis Horwood International Publishing, Surrey, United Kingdom, pp 297–312
Garcia-Cuerpo E, Kajander EO, Çiftçioğlu N, Castellano FJ, Correa C, Gonzales J, Mampaso F, Liano F, De Gabiola EG, Berrilero YA 2000 Nanobacteria: un modelo de neo-litogenesis experimental. Arch Esp Urol 53: 291–303
Schwartz MK, Lieske JC, Hunter LW, Miller VM 2009 Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits. Am J Physiol Heart Circ Physiol 296: H1434–H1441
Çiftçioğlu N, Björklund M, Kajander EO 1998 Stone formation and calcification by nanobacteria in human body. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, San Jose, CA, 3441: 105–111
Kajander EO, Kuronen I, Åkerman K, Pelttari A, Çiftçioğlu N 1997 Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. In: Hoover RB (ed) Instruments, Methods, and Missions for the Investigation of Extraterrestrial Microorganisms, Proceedings of SPIE, San Diego, CA, 3111: 420–428
Schwartz MK, Hunter LW, Huebner M, Lieske JC, Miller VM 2009 Characterization of biofilm formed by human-derived nanoparticles. Nanomedicine 4: 931–941
Evan AP, Bledsoe SB, Connors BA, Deng L, Liang L, Shao C, Fineberg NS, Grynpas MD, Stambrook PJ, Youzhi S, Sahota A, Tischfield JA 2001 Sequential analysis of kidney stone formation in the Aprt knockout mouse. Kidney Int 60: 910–923
Naito Y, Ohtawara Y, Kageyama S, Nakano M, Ichiyama A, Fujita M, Suzuki K, Kawabe K, Kino I 1997 Morphological analysis of renal cell culture models of calcium phosphate stone formation. Urol Res 25: 59–65
Çiftçioglu N, Haddad RS, Golden DC, Morrison DR, McKay DS 2005 A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int 67: 483–491
Becker W, Marxen J, Epple M, Reelsen O 2000 Influence of microgravity on crystal formation in biomineralization. J Appl Physiol 89: 1601–1607
Whitson PA, Pietrzyk RA, Sams CF 2001 Urine volume and its effects on renal stone risk in astronauts. Aviat Space Environ Med 72: 368–372
Pak CY, Hill K, Cintron NM, Huntoon C 1989 Assessing applicants to the NASA flight program for their renal stone-forming potential. Aviat Space Environ Med 60: 157–161
McCarthy ID 2005 Fluid shifts due to microgravity and their effects on bone: a review of current knowledge. Ann Biomed Eng 33: 95–103
Jones JA, Jennings R, Pietryzk R, Ciftcioglu N, Stepaniak P 2005 Genitourinary issues during spaceflight: a review. Int J Impot Res 17: S64–S67
Jones JA, Çiftçioğlu N, Schmid JF, Barr YR, Griffith D 2009 Calcifying nanoparticles (nanobacteria): an additional potential factor for urolithiasis in space flight crews. Urology 73: 210.e11–210.e13
Young JD, Martel J, Young L, Wu CY, Young A, Young D 2009 Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 4: e4417
Martel J, Young JD 2008 Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci USA 105: 5549–5554
Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, Fourquet P, Campagna B, La Scola B, Mege JL, Mansuelle P, Lechevalier E, Berland Y, Gorvel JP, Renesto P 2008 Nanobacteria are mineralo fetuin complexes. PLoS Pathog 4: e41
Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ 2000 An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 97: 11511–11515
Maniloff J, Nealson KH, Psenner R, Loferer M, Folk RL 1997 Nannobacteria: size limits and evidence. Science 276: 1773–1776
Glass JI, Assad-Garcia N, Alperovich N, Yooseph S, Lewis MR, Maruf M, Hutchison CA 3rd, Smith HO, Venter JC 2006 Essential genes of a minimal bacterium. Proc Natl Acad Sci USA 103: 425–430
Cranton E Rest in peace nanobacteria, you were not alive after all. Available at: http://www.drcranton.com/nanobacteria.htm. Accessed December 5, 2009
Vali H, McKee MD, Çiftçioğlu N, Sears SK, Plows FL, Chevet E, Ghiasi P, Plavsic M, Kajander EO, Zare RN 2001 Nanoforms: a new type of protein-associated mineralization. Geochim Cosmochim Acta 65: 63–74
Miller VM, Hunter LW, Chu K, Kaul V, Squillace PD, Lieske JC, Jayachandran M 2009 Biologic nanoparticles and platelet reactivity. Nanomed 4: 725–733
Kumar V, Farell G, Harrington S, Fitzpatrick L, Rzewuska E, Miller VM, Lieske JC 2006 Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med 54: 412–424
Shiekh FA, Miller VM, Lieske JC 2009 Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence. Clin Nephrol 71: 1–8
Sommer AP, Hassinen HI, Kajander EO 2002 Light induced replication of nanobacteria: A preliminary report. J Clin Laser Med Surg 20: 241–244
Bullard T, Freudenthal J, Avagyan S, Kahr B 2007 Test of Cairns-Smith's ‘crystals-as-genes' hypothesis. Faraday Discuss 136: 231–245; discussion 309–328.
Pereto J 2005 Controversies on the origin of life. Int Microbiol 8: 23–31
Pennisi E 2007 DNA study forces rethink of what it means to be a gene. Science 316: 1556–1557
Shapiro R 2006 Small molecule interactions were central to the origin of life. Q Rev Biol 81: 105–125
Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL, Zhao J 2006 Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 43: 1864–1871
Çiftçioğlu N, Kuronen I, Åkerman K, Hiltunen E, Laukkanen J, Kajander EO 1997 A new potential threat in antigen and antibody products: nanobacteria. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E (eds) Vaccines 97. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 99–103
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Aeronautics and Space Administration Exobiology Program.
Rights and permissions
About this article
Cite this article
Çiftçioğlu, N., McKay, D. Pathological Calcification and Replicating Calcifying-Nanoparticles: General Approach and Correlation. Pediatr Res 67, 490–499 (2010). https://doi.org/10.1203/PDR.0b013e3181d476ce
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e3181d476ce
This article is cited by
-
Calcium orthophosphates (CaPO4): occurrence and properties
Progress in Biomaterials (2016)
